Search clinical trials for: LY3871801
Total 16 results
-
Eli Lilly and CompanyRigel PharmaceuticalsRecruitingRheumatoid ArthritisUnited States, France, United Kingdom, Argentina, Mexico, India, Czechia, Germany, Slovakia
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompleted
-
Nektar TherapeuticsEli Lilly and CompanyCompleted
-
Nektar TherapeuticsEli Lilly and CompanyCompleted
-
Nektar TherapeuticsEli Lilly and CompanyCompleted
-
Nektar TherapeuticsEli Lilly and CompanyCompleted
-
Nektar TherapeuticsEli Lilly and CompanyCompleted
-
Nektar TherapeuticsEli Lilly and CompanyCompletedSystemic Lupus ErythematosusUnited States
-
Nektar TherapeuticsEli Lilly and CompanyTerminatedColitis, UlcerativeAustralia, India, United States, Korea, Republic of, Hungary, United Kingdom, Japan, Argentina, Belgium, Brazil, Canada, China, Czechia, France, Georgia, Israel, Latvia, Poland, Romania, Russian Federation, Slovakia, Ukraine
-
Nektar TherapeuticsRecruitingModerate to Severe Atopic DermatitisUnited States, Australia, Canada
-
Nektar TherapeuticsRecruiting
-
Nektar TherapeuticsEli Lilly and CompanyCompletedSystemic Lupus ErythematosusUnited States, Spain, Japan, India, Israel, Korea, Republic of, Taiwan, Australia, Puerto Rico, Argentina, Romania, Canada, Germany, Russian Federation, Mexico, Ukraine, Poland, Czechia, Hungary
-
Nektar TherapeuticsEli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompleted